SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-17-000009
Filing Date
2017-10-31
Accepted
2017-10-31 09:22:40
Documents
62
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09301710-q.htm 10-Q 974034
2 EXHIBIT 31.1 a093017ex311.htm EX-31.1 14803
3 EXHIBIT 31.2 a093017ex312.htm EX-31.2 14050
4 EXHIBIT 32.1 a093017ex321.htm EX-32.1 11772
  Complete submission text file 0001100412-17-000009.txt   6198264

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20170930.xml EX-101.INS 1265821
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20170930.xsd EX-101.SCH 48639
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20170930_cal.xml EX-101.CAL 67246
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20170930_def.xml EX-101.DEF 321912
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20170930_lab.xml EX-101.LAB 679874
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20170930_pre.xml EX-101.PRE 439497
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 171164294
SIC: 2834 Pharmaceutical Preparations